Netherlands
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
33.25 |
Feb. 5, 2025 | USD 667.09 | 1.81% |
|
Netherlands |
|
2 |
1.31 |
Feb. 5, 2025 | USD 129.11 | 4.28% |
|
Netherlands |
|
3 |
1.29 |
Feb. 5, 2025 | USD 27.32 | 1.49% |
|
Netherlands |
|
4 |
0.34 |
Feb. 5, 2025 | USD 36.38 | 0.42% |
|
Netherlands |
The Healthcare company in Netherlands with the highest Price to Sales Ratio (P/S) is argenx SE (Brussels Stock Exchange: ARGX.BR) at 33.25.
The Healthcare company in Netherlands with the lowest Price to Sales Ratio (P/S) is Koninklijke Ahold Delhaize N.V. (Amsterdam Stock Exchange: AD.AS) at 0.34.
The top 10 Healthcare companies in Netherlands by Price to Sales Ratio (P/S) are argenx SE, Redcare Pharmacy NV, Koninklijke Philips N.V. and Koninklijke Ahold Delhaize N.V..
The bottom 10 Healthcare companies in Netherlands by Price to Sales Ratio (P/S) are Koninklijke Ahold Delhaize N.V., Koninklijke Philips N.V., Redcare Pharmacy NV and argenx SE.